Aethlon Medical Inc.
Aethlon Medical Inc. (AEMD): 1 pipeline candidate · ~11 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
11.3 months
D/E 0.20 · 0% dilution
Lead: Preclinical
1 candidate
N/A
N/A
A transparent, data-derived signal for Aethlon Medical Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$4.6M
Cash
$7.1M
Quarterly Burn
$1.9M
Runway
11.3 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (1 candidate)
| Drug | Phase |
|---|---|
| hemopurifier | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
7
Total value held
$87K
| Holder | Shares | Value |
|---|---|---|
| geode capital management, llc | 24,364 | $53K |
| xtx topco ltd | 13,342 | $29K |
| morgan stanley | 2,047 | $4K |
| group one trading llc | 14 | $31 |
| blackrock, inc. | 10 | $22 |
| wells fargo & company/mn | 3 | $6 |
| danske bank a/s | 1 | $2 |
Frequently asked questions
How many drug candidates are in Aethlon Medical Inc.'s pipeline?
Aethlon Medical Inc. (AEMD) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Aethlon Medical Inc.'s lead drug candidate?
Aethlon Medical Inc.'s most advanced tracked candidate is hemopurifier (Preclinical) for Life-threatening viral infections.
What is Aethlon Medical Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Aethlon Medical Inc. has approximately 11.3 months of cash runway.
What is Aethlon Medical Inc.'s market capitalization?
Aethlon Medical Inc.'s market capitalization is approximately $4.6M.
Who is the CEO of Aethlon Medical Inc.?
Mr. James B. Frakes M.B.A. is the chief executive officer of Aethlon Medical Inc. (AEMD).
Get the full picture on Aethlon Medical Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.